Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study.

Front Immunol · 2023 · PMC10639171 · PMID 37954615

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a strong trendp =0.060so close (0.05 < p ≤ 0.1)

ECOG scores also had a strong trend toward lowering the OS (HR, 1.9; 95% CI, 0.97-3.7; p =0.060), RFS (HR, 1.9; 95% CI, 0.99-3.8; p =0.054), and GRFS (HR, 1.7; 95% CI, 0.92-3.1; p =0.089). 3.5.

also in 1,845 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.